SCHEMBL282439

SCHEMBL282439

CCOP(=O)(CC(=O)O)OCC

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.52
PPARD Q03181 2/20 0.50
TDP1 Q9NUW8 2/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42
BLM P54132 1/20 0.42
KMT2A Q03164 1/20 0.42
TP53 P04637 1/20 0.40
MAPT P10636 2/20 0.38
MAPK1 P28482 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
FFAR3 O14843 1/20 0.36
POLB P06746 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2298239 0.98 TSHR (0.50) TSHRPPARDTDP1MEN1LMNA
SCHEMBL28021215 0.98 TSHR (0.50) TSHRPPARDTDP1MEN1LMNA
Hydrochloric Acid SCHEMBL15439306 0.98 TSHR (0.50) TSHRPPARDTDP1MEN1LMNA
Butane SCHEMBL2079484 0.95 TSHR (0.48) TSHRPPARDTDP1MEN1LMNA
Ether SCHEMBL28022888 0.93 TSHR (0.46) TSHRPPARDTDP1MEN1LMNA
Propene SCHEMBL28006041 0.89 TSHR (0.43) TSHRPPARDTDP1MEN1LMNA
SCHEMBL7528773 0.89 TSHR (0.43) TSHRPPARDTDP1MEN1LMNA
Acrylic Acid SCHEMBL28624578 0.88 TSHR (0.41) TSHRPPARDTDP1MEN1LMNA
SCHEMBL9332124 0.82 TSHR (0.44) TSHRPPARDTDP1MEN1KMT2A
SCHEMBL18250731 0.82 TSHR (0.55) TSHRPPARDTDP1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1921 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4690337-A2 PHOSPHOROUS ELECTROLYTE ADDITIVES FOR AQUEOUS BATTERIES Octet Scientific, Inc. (US) 2026-02-11 EP claimed
US-20260031409-A1 PHOSPHOROUS ELECTROLYTE ADDITIVES FOR AQUEOUS BATTERIES OCTET SCIENT INC (US) 2026-01-29 US claimed
EP-4661890-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS Purdue Research Foundation (US) 2025-12-17 EP claimed
US-20250075020-A1 WATER-RETAINING MATERIAL, WATER-RETAINING PROTON EXCHANGE MEMBRANE, PREPARATION METHOD AND APPLICATION THEREOF SOUTHERN UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2025-03-06 US claimed
WO-2025043316-A1 PROCESS FOR OBTAINING ANTI-INFLAMMATORY COMPOUNDS, SAID COMPOUNDS, PHARMACEUTICAL COMPOSITION AND USE OF SAID COMPOUNDS AND OF THE PHARMACEUTICAL COMPOSITION UNIVERSIDADE ESTADUAL DE CAMPINAS (BR) 2025-03-06 WO claimed
US-20240400793-A1 COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. 2024-12-05 US claimed
WO-2024211760-A2 PHOSPHOROUS ELECTROLYTE ADDITIVES FOR AQUEOUS BATTERIES Octet Scientific, Inc. (US) 2024-10-10 WO claimed
WO-2024167565-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS PURDUE RESEARCH FOUNDATION (US) 2024-08-15 WO claimed
CN-118434796-A Composition for polyurethane foam, foam prepared therefrom and method thereof 迈图高新材料公司 2024-08-02 CN claimed
EP-4396271-A1 COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF Momentive Performance Materials Inc. (US) 2024-07-10 EP claimed
EP-1276483-A2 COMPOSITIONS AND METHODS FOR TREATING AMYLOIDOSIS USING SULPHONATE DERIVATIVES QUEEN'S UNIVERSITY AT KINGSTON (CA) 2003-01-22 EP claimed
EP-1255757-A1 AMINO ACID DERIVATIVES AND USE THEREOF AS NEP, ACE AND ECE INHIBITORS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2002-11-13 EP claimed
US-20020115717-A1 Amyloid targeting imaging agents and uses thereof NEUROCHEM (INTERNATIONAL) LIMITED (GI) 2002-08-22 US claimed
WO-2002007781-A2 AMYLOID TARGETING IMAGING AGENTS AND USES THEREOF NEUROCHEM INC. (CA) 2002-01-31 WO claimed
WO-2001060822-A1 AMINO ACID DERIVATIVES AND USE THEREOF AS NEP, ACE AND ECE INHIBITORS INSTITUT NATIONAL DE LA RECHERCHE MEDICALE INSERM (FR) 2001-08-23 WO claimed
WO-2000064420-A2 COMPOSITIONS AND METHODS FOR TREATING AMYLOIDOSIS USING SULPHONATE DERIVATIVES QUEEN'S UNIVERSITY AT KINGSTON (CA) 2000-11-02 WO claimed
JP-2000500758-A 2000-01-25 JP claimed
EP-0862575-A1 NOVEL GERANYLGERANYL-DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND RELATED PHARMACEUTICAL COMPOSITIONS LABORATORI BALDACCI Spa (IT) 1998-09-09 EP claimed
EP-0259227-B1 BENZHYDRYLOXYETHYL PIPERIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Société anonyme: LES LABORATOIRES MERAM (FR) 1991-12-27 EP claimed
EP-0259227-A1 Benzhydryloxyethyl piperidine derivatives, process for their preparation and pharmaceutical compositions containing them Société anonyme: LES LABORATOIRES MERAM (FR) 1988-03-09 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260031409-A1 PHOSPHOROUS ELECTROLYTE ADDITIVES FOR AQUEOUS BATTERIES H1-10, SLC9A1, HAO2 TSHR 3102/4885PPARD 4219/4885TDP1 1099/4885
US-20020115717-A1 Amyloid targeting imaging agents and uses thereof APP, APBA1, BACE1 TSHR 4314/4885PPARD 4582/4885TDP1 1268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.